FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2162600 · Received July 14, 2011

Report

Report Number
2124215-2011-07634
Event Type
Injury
Date Received
July 14, 2011
Date of Event
April 20, 2011
Report Date
May 10, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE COMPLETE LEAD WAS RETURNED WITH A SET SCREW MARK NOTED ON ALL TERMINAL CONNECTORS. DURING TESTING THE HELIX MECHANISM WOULD NOT EXTEND DUE TO DRIED BLOOD IN MECHANISM. THE LEAD WAS SUBJECT TO DIRECT CURRENT RESISTANCE TESTING AND PASSED ON ALL PATHS, VERIFYING THE LEAD'S ELECTRICAL PERFORMANCE WAS INTACT. NO FURTHER TESTING WAS PERFORMED ANALYSIS COULD NOT CONFIRM THE CLINICAL ALLEGATIONS OBSERVED IN THE FIELD.

Additional Manufacturer Narrative · 1

THE PRODUCT HAS BEEN RECEIVED AND IS CURRENTLY BEING ANALYZED. WHEN TESTING IS COMPLETE THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A ROUTINE FOLLOW-UP VISIT, THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED NOISE WITH OVERSENSING AND PACING INHIBITION. IT WAS NOTED THAT THE SENSING ON THE LEAD HAS BEEN DECREASING OVER THE LAST YEAR. THE PATIENT WAS ADMITTED TO THE HOSPITAL FOR A LEAD REVISION PROCEDURE. THE RV LEAD WAS EXPLANTED AND A NEW LEAD WAS SUCCESSFULLY IMPLANTED. NO INAPPROPRIATE THERAPY OCCURRED DUE TO THE NOISE. NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT OF THE LEAD REVISION PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0185

Patients

Seq Age Sex Outcome Treatment
1 77 YR Hospitalization| L| R 0185| 4518| 1298| 4456| 4469| N118